Kuros Biosciences AG KUROS BIOSCI.../ CH0325814116 /
2024-05-17 10:26:48 AM | Chg. +0.220 | Volume | Bid2024-05-16 | Ask2024-05-16 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
8.250CHF | +2.74% | 1,000 Turnover: 8,250 |
-Bid Size: - | -Ask Size: - | 291.03 mill.CHF | - | - |
GlobeNewswire
05-17
INVESTIGATION ANNOUNCEMENT BFA LLP Announces an Ongoing Investigation into the Directors of Ventyx B...
GlobeNewswire
05-16
Ventyx Biosciences Announces Appointment of Matthew Moore as Chief Operating Officer
GlobeNewswire
05-16
LIfT BioSciences Awarded Innovate UK Grant to Accelerate Product Development of New IMAN Cell Therap...
Newsfile Corp
05-15
Maxwell Biosciences CEO J. Scotch McClure Named Top 25 Executive in Biotechnology
GlobeNewswire
05-15
Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewswire
05-15
Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results
GlobeNewswire
05-14
VENTYX BIOSCIENCES, INC. (NASDAQ: VTYX) SHAREHOLDER ALERT: The Directors of Ventyx Biosciences, Inc....
GlobeNewswire
05-14
Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update
GlobeNewswire
05-13
Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-11
VENTYX BIOSCIENCES, INC. INVESTOR ALERT (NASDAQ: VTYX): The Directors of Ventyx Biosciences, Inc. Ar...
GlobeNewswire
05-10
Tome Biosciences Presented Data on its Programmable Genomic Integration Technologies at ASGCT
GlobeNewswire
05-09
Coherus BioSciences Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
05-09
Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
GlobeNewswire
05-09
Ventyx Biosciences Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Prog...
GlobeNewswire
05-09
Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Sele...
GlobeNewswire
05-09
Aura Biosciences Reports First Quarter 2024 Financial Results and Business Highlights
GlobeNewswire
05-09
Nxera Pharma’s partner Neurocrine Biosciences Initiates Phase 1 Clinical Study Evaluating Effects of...